Trisomy 21 risk based on maternal age+Pregnancy associated plasma protein A+Choriogonadotropin+Nuchal translucency [Likelihood] in Fetus

Q: Why is Trisomy 21 risk based on maternal age+Pregnancy associated plasma protein A+Choriogonadotropin+Nuchal translucency [Likelihood] in Fetus ordered?

Providers order this test when results can help evaluate symptoms, monitor conditions, or guide treatment.

Q: How do I prepare for Trisomy 21 risk based on maternal age+Pregnancy associated plasma protein A+Choriogonadotropin+Nuchal translucency [Likelihood] in Fetus?

Preparation depends on the specific test and your provider’s instructions.

LOINC: 49030-0Type: OtherCPT: N/A

Medical Disclaimer: This information is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making any health-related decisions.

Frequently Asked Questions

A diagnostic test used to support clinical decision-making.

Sources

[1]LOINC — Logical Observation Identifiers Names and Codes. Regenstrief Institute

Trisomy 21 risk based on maternal age+Pregnancy associated plasma protein A+Choriogonadotropin+Nuchal translucency [Likelihood] in Fetus

Frequently Asked Questions

What is Trisomy 21 risk based on maternal age+Pregnancy associated plasma protein A+Choriogonadotropin+Nuchal translucency [Likelihood] in Fetus?

Why is Trisomy 21 risk based on maternal age+Pregnancy associated plasma protein A+Choriogonadotropin+Nuchal translucency [Likelihood] in Fetus ordered?

How do I prepare for Trisomy 21 risk based on maternal age+Pregnancy associated plasma protein A+Choriogonadotropin+Nuchal translucency [Likelihood] in Fetus?